Xinzhou Deng

Hubei University of Medicine — China

Biochemistry, Genetics and Molecular Biology · Life Sciences

15h-index715citations38works3.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

RNA modifications and cancer(9), Glycosylation and Glycoproteins Research(7), Ferroptosis and cancer prognosis(7), Galectins and Cancer Biology(6), Curcumin's Biomedical Applications(4)

Publications38 total

Correction: Case Report: The integration of chemoradiotherapy and immunotherapy in a patient with advanced-stage renal squamous cell carcinoma and pulmonary metastases
Frontiers in Immunology·2025Open Access
Proline Intake Dampens Radiosensitivity in Prostate Cancer Cells by Targeting PRODH/MAPK Pathway
Radiation Research·2025
Case Report: The integration of chemoradiotherapy and immunotherapy in a patient with advanced-stage renal squamous cell carcinoma and pulmonary metastases
Frontiers in Immunology·2025Open Access
Nanobodies and their derivatives: pioneering the future of cancer immunotherapy
Cell Communication and Signaling·2025· 15 citedOpen Access
Metallothionein 2A as a prognostic marker promotes glioma progression
2024Open Access
Pan-Cancer Analysis of the Prognostic and Immunological Role of HCCS: A Potential Target for Survival and Immunotherapy
Research Square (Research Square)·2023Open Access
Suppresses of LIM kinase 2 promotes radiosensitivity in radioresistant non-small cell lung cancer cells
Heliyon·2023· 2 citedOpen Access
Pan-cancer analysis identified OAS1 as a potential prognostic biomarker for multiple tumor types
Frontiers in Oncology·2023· 11 citedOpen Access
<scp>GRAP2</scp> is a prognostic biomarker and correlated with immune infiltration in lung adenocarcinoma
Journal of Clinical Laboratory Analysis·2022· 11 citedOpen Access
GRAP2 is a Prognostic Biomarker and Correlated with Immune Infiltration in Lung Adenocarcinoma
Research Square (Research Square)·2022Open Access
Construction and investigation of β3GNT2-associated regulatory network in esophageal carcinoma
Cellular & Molecular Biology Letters·2022· 7 citedOpen Access
GRAP2 is a Prognostic Biomarker and Correlated with Immune Infiltration in Lung Adenocarcinoma
Research Square (Research Square)·2022· 3 citedOpen Access
GPI Is a Prognostic Biomarker and Correlates With Immune Infiltrates in Lung Adenocarcinoma
Frontiers in Oncology·2021· 47 citedOpen Access
A novel mechanism for C1GALT1 in the regulation of gastric cancer progression
Cell & Bioscience·2021· 39 citedOpen Access
C1GALT1, Negatively Regulated by miR-181d-5p, Promotes Tumor Progression via Upregulating RAC1 in Lung Adenocarcinoma
Frontiers in Cell and Developmental Biology·2021· 30 citedOpen Access
Emodin enhances cisplatin sensitivity in non-small cell lung cancer through Pgp downregulation
Oncology Letters·2021· 40 citedOpen Access
IL-11 mediates the Radioresistance of Cervical Cancer Cells via the PI3K/Akt Signaling Pathway
Journal of Cancer·2021· 14 citedOpen Access
Curcumin potentiates laryngeal squamous carcinoma radiosensitivity via NF-ΚB inhibition by suppressing IKKγ expression
Journal of Receptors and Signal Transduction·2020· 16 cited
UHRF1 predicts poor prognosis by triggering cell cycle in lung adenocarcinoma
Journal of Cellular and Molecular Medicine·2020· 31 citedOpen Access
A lectin-based glycomic approach identifies FUT8 as a driver of radioresistance in oesophageal squamous cell carcinoma
Cellular Oncology·2020· 67 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Zhiguo Luo(24), Qiuping Zhang(10), Jingjing Chai(10), Qing Ke(9), Li Shen(8), Ming Luo(8), Yutao Yan(8), Zhenbo Tu(7), R. Xiao(7), Jie Xiong(7), Meng Xiong(6), Chunli Chen(6), Qiwen Duan(6), Shimao Song(6), Zhen Peng(5), Xiaoxia Dong(4), Jiahui Han(4), Xiangyong Yang(4), Li Qiu(4), Xinran Li(4)